Sens. Slam Novartis-Owned Co. For Hiding Bogus Data
Some lawmakers on Friday slammed a Novartis-owned gene therapy company for covering up data manipulation when seeking approval for a $2.1 million muscle disease medication, and pushed the U.S. Food and...To view the full article, register now.
Already a subscriber? Click here to view full article